Appili Therapeutics Inc. (TSX:APLI)

Appili Therapeutics Revenue

In the fiscal year ending March 31, 2025, Appili Therapeutics had annual revenue of 100.44K CAD, down -87.86%. Appili Therapeutics had revenue of -12.61K in the quarter ending March 31, 2025, a decrease of -207.77%.

• Revenue: 100.44K
• Revenue Growth: -87.86%
• P/S Ratio: 18.11
• Revenue / Employee: 14.35K
• Employees: 7
• Market Cap: 1.82M

Revenue History

Fiscal Year End	Revenue	Change	Growth
Mar 31, 2025	100.44K	-726.96K	-87.86%
Mar 31, 2024	827.41K	493.23K	147.60%
Mar 31, 2023	334.18K	-1.06M	-75.97%
Mar 31, 2022	1.39M	-	-
Mar 31, 2021	-	-	-